Recurrent Adult Burkitt Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +12 more
  • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • +4 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-03-29
Mar 29, 2022
S
Active, not recruiting
  • Acute Leukemias of Ambiguous Lineage
  • +4 more
  • Duarte, California
  • +4 more
2022-04-04
Apr 4, 2022
C
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
C
Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
2022-02-16
Feb 16, 2022
M
Active, not recruiting
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
2022-02-03
Feb 3, 2022
N
Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
2021-08-30
Aug 30, 2021
S
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
B
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-04-14
Apr 14, 2021
R
Completed
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +58 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-03-23
Mar 23, 2021
F
Terminated
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +32 more
  • indium In 111 anti-CD45 monoclonal antibody BC8
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021
F
Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
2021-02-01
Feb 1, 2021
M
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
2020-09-28
Sep 28, 2020
M
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +27 more
  • Scottsdale, Arizona
  • +2 more
2020-03-02
Mar 2, 2020
F
Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
2020-01-15
Jan 15, 2020
F
Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
2020-01-17
Jan 17, 2020
F
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +134 more
  • fludarabine phosphate
  • +6 more
  • Stanford, California
  • +9 more
2020-01-15
Jan 15, 2020
N
Completed
  • Adult B Acute Lymphoblastic Leukemia
  • +37 more
  • Bendamustine Hydrochloride
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2019-11-22
Nov 22, 2019
R
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2019-10-30
Oct 30, 2019
F
Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
2019-10-29
Oct 29, 2019
R
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +77 more
  • fludarabine phosphate
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2019-09-16
Sep 16, 2019
U
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +63 more
  • therapeutic allogeneic lymphocytes
  • laboratory biomarker analysis
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2019-07-17
Jul 17, 2019